VINYLOGOUS HYDROXAMIC ACIDS - 5-LIPOXYGENASE INHIBITORS

被引：2
|
作者：
WRIGHT, SW
PINTO, DJ
SHERK, SR
GREEN, AM
MAGOLDA, RL
机构：
[1] The Du Pont Merck Pharmaceutical Company, Du Pont Experimental Station, Wilmington
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1992年 / 2卷 / 09期
关键词：
D O I：
10.1016/S0960-894X(00)80622-8
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Vinylogous hydroxamic acids were prepared as inhibitors of 5-lipoxygenase. The synthesis and preliminary SAR of these relatively unexplored compounds are described. These compounds are potent 5-lipoxygenase inhibitors which do not inhibit other enzymes of the arachidonic acid cascade.
引用
收藏
页码：1079 / 1084
页数：6
相关论文
共 50 条
  • [31] Benzoxazole and pyridinothiazoles as 5-lipoxygenase inhibitors
    Choo, Hea-Young Park
    Oh, Sei-Ryang
    Lee, Hyeong-Kyu
    Ann, Kyeongsup
    Han, Gyoonhee
    Kim, Joo-Heon
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 631 - 631
  • [32] 5-lipoxygenase inhibitors for the treatment of COPD
    Kilfeather, S
    CHEST, 2002, 121 (05) : 197S - 200S
  • [33] Recent developments in 5-lipoxygenase inhibitors
    Julémont, F
    Dogné, JM
    Laeckmann, D
    Pirotte, B
    de Leval, X
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (01) : 1 - 13
  • [34] Therapeutic options for 5-lipoxygenase inhibitors
    Werz, Oliver
    Steinhilber, Dieter
    PHARMACOLOGY & THERAPEUTICS, 2006, 112 (03) : 701 - 718
  • [35] Studies on 5-lipoxygenase inhibitors. I. Synthesis and 5-lipoxygenase-inhibitory activity of novel hydroxamic acid derivatives
    Yatabe, T
    Kawai, Y
    Oku, T
    Tanaka, H
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1998, 46 (06) : 966 - 972
  • [36] CONVERSION OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS INTO EITHER DUAL INHIBITORS OF 5-LIPOXYGENASE AND CYCLOOXYGENASE OR INTO SELECTIVE INHIBITORS OF 5-LIPOXYGENASE
    BOSCHELLI, DH
    CONNOR, DT
    BORNEMEIER, DA
    DYER, RD
    KUIPERS, PJ
    WRIGHT, CD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 123 - MEDI
  • [37] STUDIES ON THE SYNTHESIS OF 5-LIPOXYGENASE INHIBITORS
    SHIRAISHI, M
    KATO, K
    OHKAWA, S
    TERAO, S
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1984, 7 (05): : S95 - S95
  • [38] Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis
    Back, Magnus
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (27) : 3116 - 3132
  • [39] Conversion of cyclooxygenase inhibitors into hydroxythiazole 5-lipoxygenase inhibitors
    Kerdesky, FAJ
    Brooks, CDW
    Hulkower, KI
    Bouska, JB
    Bell, RL
    BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (02) : 393 - 396
  • [40] Nonredox 5-lipoxygenase inhibitors require glutathione peroxidase for efficient inhibition of 5-lipoxygenase activity
    Werz, O
    Szellas, D
    Henseler, M
    Steinhilber, D
    MOLECULAR PHARMACOLOGY, 1998, 54 (02) : 445 - 451
12345